Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications i…
Medical - Diagnostics & Research
US, San Diego [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 174.00 | 272.00 | 358.00 | 291.00 | 386.00 | 501.00 | 659.00 | 687.00 | 875.00 | 1,142.00 | 1,051.00 | 1,080.00 | 545.00 | 392.00 | 477.00 | |
| Operating Cash (Net) | 174.00 | 272.00 | 358.00 | 291.00 | 386.00 | 501.00 | 659.00 | 687.00 | 875.00 | 1,142.00 | 1,051.00 | 1,080.00 | 545.00 | 392.00 | 477.00 | |
| Accounts Receivable | -18.00 | -7.00 | -7.00 | -34.00 | -15.00 | -50.00 | -95.00 | 3.00 | -26.00 | -105.00 | -58.00 | 89.00 | -164.00 | -12.00 | -40.00 | |
| Accounts Payable | 11.00 | 23.00 | -21.00 | 15.00 | 2.00 | -2.00 | 46.00 | -1.00 | 10.00 | 45.00 | -35.00 | 40.00 | 60.00 | -38.00 | -44.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -11.00 | -2.00 | 37.00 | -17.00 | 153.00 | -56.00 | -38.00 | -45.00 | 195.00 | -18.00 | -194.00 | 73.00 | -152.00 | 204.00 | -90.00 | |
| Other WC | 14.00 | 31.00 | 42.00 | 25.00 | 160.00 | 32.00 | 91.00 | -16.00 | 244.00 | 95.00 | -126.00 | -44.00 | 10.00 | 389.00 | 14.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -255.00 | -285.00 | -400.00 | -150.00 | -69.00 | -406.00 | -106.00 | -514.00 | -214.00 | -1,813.00 | 745.00 | -554.00 | -1,069.00 | -591.00 | -231.00 | |
| Capital Expenditure | -55.00 | -56.00 | -79.00 | -81.00 | -90.00 | -142.00 | -143.00 | -271.00 | -312.00 | -296.00 | -209.00 | -189.00 | -208.00 | -466.00 | -196.00 | |
| Purchases of Investments | -714.00 | -873.00 | -1,324.00 | -941.00 | -364.00 | -803.00 | -803.00 | -908.00 | -771.00 | -2,874.00 | -1,030.00 | -1,926.00 | -129.00 | -40.00 | -6.00 | |
| Sale/Maturity of Investment | 515.00 | 743.00 | 1,060.00 | 898.00 | 812.00 | 541.00 | 876.00 | 682.00 | 921.00 | 1,457.00 | 2,016.00 | 1,791.00 | 1,712.00 | 180.00 | 36.00 | |
| Property, Plant, Equipment (P&PE) | -55.00 | -56.00 | -79.00 | -81.00 | -90.00 | -142.00 | -143.00 | -271.00 | -312.00 | -296.00 | -209.00 | -189.00 | -208.00 | -466.00 | -196.00 | |
| Acquisitions (Net) | -1.00 | -98.00 | -58.00 | -32.00 | -427.00 | -3.00 | -36.00 | -17.00 | -52.00 | -100.00 | -32.00 | -98.00 | -2,444.00 | -85.00 | -29.00 | |
| Other Investing Activities | -255.00 | -285.00 | -400.00 | 6.00 | 533.00 | -297.00 | 73.00 | -237.00 | 96.00 | -1,417.00 | -18.00 | -132.00 | 1,583.00 | -180.00 | -36.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -98.00 | -116.00 | -97.00 | -10.00 | -38.00 | -166.00 | -418.00 | -204.00 | -176.00 | -594.00 | -897.00 | -766.00 | -51.00 | -1,000.00 | -1,209.00 | |
| Debt Repayment | -10.00 | - - | -349.00 | - - | -10.00 | -1,274.00 | -244.00 | -65.00 | -9.00 | -4.00 | -550.00 | - - | -517.00 | -991.00 | -1,235.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
214 | 146 | 632 | 136 | 50 | 333 | 346 | 297 | 322 | 247 | 383 | 797 | 571 | 117 | 107 | |
| Issued | 39.00 | 102.00 | 61.00 | 54.00 | - - | 96.00 | 71.00 | 47.00 | 71.00 | 46.00 | 59.00 | 61.00 | 60.00 | 63.00 | 67.00 | |
| Repurchased | -175.00 | -44.00 | -570.00 | -82.00 | -50.00 | -237.00 | -274.00 | -249.00 | -251.00 | -201.00 | -324.00 | -736.00 | -511.00 | -54.00 | -40.00 | |
| Other Financing Activities | 192.00 | 58.00 | 1,813.00 | 17.00 | 22.00 | 2,381.00 | 28.00 | 74.00 | 18.00 | 1,488.00 | -82.00 | -91.00 | 1,428.00 | 2,919.00 | -41.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 327.00 | 144.00 | 248.00 | 302.00 | 433.00 | 711.00 | 636.00 | 768.00 | 735.00 | 1,225.00 | 1,144.00 | 2,042.00 | 1,810.00 | 1,232.00 | 2,011.00 | |
| End of Period | 144.00 | 248.00 | 302.00 | 433.00 | 711.00 | 636.00 | 768.00 | 734.00 | 1,225.00 | 1,144.00 | 2,042.00 | 1,810.00 | 1,232.00 | 2,011.00 | 1,048.00 | |
| Change | -182.00 | 104.00 | 54.00 | 131.00 | 277.00 | -75.00 | 132.00 | -34.00 | 490.00 | -81.00 | 898.00 | -232.00 | -578.00 | 779.00 | -963.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 31.00 | 42.00 | 68.00 | 63.00 | 97.00 | 112.00 | 126.00 | 140.00 | 156.00 | 179.00 | 188.00 | 187.00 | 251.00 | 394.00 | 432.00 | |
| Stock Based Compensation | 60.00 | 71.00 | 92.00 | 94.00 | 105.00 | 152.00 | 132.00 | 129.00 | 164.00 | - - | 194.00 | 194.00 | 754.00 | 366.00 | 380.00 | |
| Other | -8.00 | -12.00 | 101.00 | 22.00 | -59.00 | -160.00 | -98.00 | -59.00 | -399.00 | 24.00 | -138.00 | -147.00 | -994.00 | 3,855.00 | 949.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | 119.00 | 216.00 | 278.00 | 210.00 | 295.00 | 359.00 | 516.00 | 415.00 | 563.00 | 846.00 | 842.00 | 891.00 | 337.00 | -74.00 | 281.00 | |
| Cash Conversion Cycle (CCC) | 157.00 | 158.00 | 143.00 | 158.00 | 119.00 | 127.00 | 135.00 | 138.00 | 122.00 | 127.00 | 130.00 | 118.00 | 78.00 | 115.00 | 132.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | -2.00 | - - | - - | - - | - - | -3.00 | -2.00 | -2.00 | 5.00 | -4.00 | -1.00 | 8.00 | -3.00 | -22.00 | - - |